REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 131 filers reported holding REVOLUTION MEDICINES INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,029,418 | +8.6% | 145,572 | +5.0% | 0.01% | +25.0% |
| Q2 2023 | $3,709,636 | +128261.1% | 138,678 | +3.9% | 0.00% | 0.0% |
| Q1 2023 | $2,890 | +2.2% | 133,415 | +12.4% | 0.00% | 0.0% |
| Q4 2022 | $2,828 | -99.9% | 118,737 | +9.8% | 0.00% | +33.3% |
| Q3 2022 | $2,132,000 | +20.3% | 108,102 | +18.9% | 0.00% | 0.0% |
| Q2 2022 | $1,772,000 | -8.5% | 90,903 | +19.7% | 0.00% | +50.0% |
| Q1 2022 | $1,937,000 | -3.9% | 75,943 | -5.1% | 0.00% | 0.0% |
| Q4 2021 | $2,015,000 | -9.4% | 80,056 | -0.9% | 0.00% | -33.3% |
| Q3 2021 | $2,223,000 | -10.4% | 80,810 | +3.3% | 0.00% | 0.0% |
| Q2 2021 | $2,482,000 | +18.1% | 78,201 | +70.8% | 0.00% | 0.0% |
| Q1 2021 | $2,101,000 | +14.6% | 45,794 | -1.2% | 0.00% | 0.0% |
| Q4 2020 | $1,834,000 | +26.9% | 46,327 | +11.6% | 0.00% | +50.0% |
| Q3 2020 | $1,445,000 | +143.3% | 41,528 | +120.8% | 0.00% | +100.0% |
| Q2 2020 | $594,000 | +89.2% | 18,809 | +31.3% | 0.00% | 0.0% |
| Q1 2020 | $314,000 | – | 14,322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |